Affiliation:
1. UCSF: University of California San Francisco
2. U-M: University of Michigan
3. University of California San Francisco
Abstract
Abstract
Randomized controlled trials reported in the literature are often affected by poor generalizability, and pragmatic trials have become an increasingly utilized workaround approach to overcome logistical limitations and explore routine interventions demonstrating equipoise in clinical practice. Intravenous albumin, for example, is commonly administered in the perioperative setting despite lacking supportive evidence. Given concerns for cost, safety, and efficacy, randomized trials are needed to explore the clinical equipoise of albumin therapy in this setting, and we therefore present an approach to identifying populations exposed to perioperative albumin to encourage clinical equipoise in patient selection and optimize study design for clinical trials.
Publisher
Research Square Platform LLC
Reference10 articles.
1. Overcoming barriers in the design and implementation of clinical trials for Acute Kidney Injury: a report from the 2020 Kidney Disease Clinical Trialists meeting;Lazzareschi D;Nephrol Dial Transplant,2022
2. Lazzareschi D, Fong N, Mavrothalassitis O et al. Intraoperative use of albumin in major non-cardiac surgery: Incidence, variability, and association with outcomes.Ann Surg2022; In print: In print
3. Considerations for Integration of Perioperative Electronic Health Records Across Institutions for Research and Quality Improvement: The Approach Taken by the Multicenter Perioperative Outcomes Group;Colquhoun DA;Anesth Analg,2020
4. Acute Intravascular Volume Expansion with Rapidly Administered Crystalloid or Colloid in the Setting of Moderate Hypovolemia;McIlroy DR;Anesth Analg,2003
5. Albumin Kinetics in Patients Undergoing Major Abdominal Surgery;Norberg Ã;PLoS ONE,2015